De-Risk and Streamline Antibody Pair-Based Immunoassay Development
01 November, 2025How to save time, reduce variability, and optimize assay performance.
Antibody treatment reprograms immune system after heart attack
30 October, 2025A new drug being trialled in heart attack patients could reprogram the immune system to prevent inflammation and heart damage following severe heart attacks.
HAWK Biosystems Quantifying Functions in Proteins (QF-Pro) reagent kits
30 October, 2025HAWK Biosystems' Quantifying Functions in Proteins (QF-Pro) reagent kits contain the tailored secondary detection reagents and specific components necessary to perform functional protein labelling in situ.
Dendritics monoclonal antibodies for dendritic cell research
22 October, 2025Dendritics' mouse and rat antibodies are logically grouped into several product families: DC subtypes, C-type lectin receptors, Toll-like receptors, DC migration, cytokines and cytokine receptors, antigen processing/presentation, and allergy.
Bioss In Vivo Biosimilar Antibodies
08 October, 2025Bioss In Vivo Biosimilar Antibodies are research-grade copies of therapeutic antibodies that are used to study how drugs work.
AdipoGen Life Sciences PANoptosis research antibodies
05 September, 2025AdipoGen Life Sciences provides thoroughly validated and published antibodies for PANoptosis, apoptosis, pyroptosis and necroptosis research.
Not all brown snake venoms are alike, causing antivenom concerns
02 September, 2025Venom from northern and southern populations of eastern brown snake builds blood clots in very different ways, meaning the antivenom given to people bitten by these snakes may not be as effective as it could be.
Proteintech blotting accelerator
01 September, 2025Proteintech's ready-to-use blotting accelerator is specifically used for membrane blocking and antibody dilution in western blot experiments, and designed to shorten the blotting workflow to around 40 min or less.
Tiny antibody found to neutralise Hendra and Nipah viruses
09 July, 2025There are no approved human vaccines for either disease, nor are there any known cures — but with the discovery of the new nanobody, that could all be about to change.
Llama antibodies open door to future coronavirus protection
24 June, 2025Researchers have discovered a novel class of small antibodies that are strongly protective against a wide range of SARS coronaviruses, including SARS-CoV-1 and numerous SARS-CoV-2 variants.
Bio-Rad Laboratories anti-idiotypic antibodies and Human IgM-FcSpyCatcher reagent
19 June, 2025Bio-Rad Laboratories has extended its range of recombinant monoclonal anti-idiotypic antibodies with the introduction of antibodies specific to pertuzumab (Perjeta), guselkumab (Tremfya), canakinumab (Ilaris), belimumab (Benlysta) and the bispecific drug emicizumab (Hemlibra).
ProSci Incorporated apoptosis antibodies
05 June, 2025ProSci Incorporated provides an extensive catalogue of apoptotic antibodies including death receptors (DR4, DR5), Bcl-2 family member proteins (Bad, Bax, Bim, Puma), caspase family proteins, p53 signalling pathway, and apoptosis regulatory molecules and enzymes.
Super-strong antibodies developed for cancer treatment
16 May, 2025Scientists discovered that their antibody prototype, which was more rigid, was able to trigger a stronger response from the immune system compared to those made by our bodies.
Newly created antivenom protects against 19 deadly snakes
06 May, 2025By using antibodies from a human donor with a self-induced hyper-immunity to snake venom, US researchers claim to have developed the most broadly effective antivenom to date.
Testing more antibodies with fewer lab mice
02 April, 2025Researchers have developed a technology that can be used to test 25 antibodies simultaneously in a single laboratory mouse.
